- Home
- WFRD vs BRKR Comparison
WFRD vs BRKR Comparison
Compare WFRD & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- BRKR
- Stock Information
- Founded
- WFRD 1941
- BRKR 1991
- Country
- WFRD United States
- BRKR United States
- Employees
- WFRD N/A
- BRKR N/A
- Industry
- WFRD Metal Fabrications
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- WFRD Industrials
- BRKR Industrials
- Exchange
- WFRD Nasdaq
- BRKR Nasdaq
- Market Cap
- WFRD 7.9B
- BRKR 7.5B
- IPO Year
- WFRD N/A
- BRKR 2000
- Fundamental
- Price
- WFRD $85.32
- BRKR $56.22
- Analyst Decision
- WFRD Strong Buy
- BRKR Buy
- Analyst Count
- WFRD 8
- BRKR 12
- Target Price
- WFRD $148.25
- BRKR $77.45
- AVG Volume (30 Days)
- WFRD 957.0K
- BRKR 1.6M
- Earning Date
- WFRD 10-22-2024
- BRKR 11-05-2024
- Dividend Yield
- WFRD 1.17%
- BRKR 0.36%
- EPS Growth
- WFRD 51.37
- BRKR N/A
- EPS
- WFRD 7.14
- BRKR 2.06
- Revenue
- WFRD $5,534,000,000.00
- BRKR $3,241,300,000.00
- Revenue This Year
- WFRD $11.61
- BRKR $15.40
- Revenue Next Year
- WFRD $3.21
- BRKR $7.78
- P/E Ratio
- WFRD $11.93
- BRKR $27.25
- Revenue Growth
- WFRD 11.08
- BRKR 15.00
- 52 Week Low
- WFRD $77.00
- BRKR $48.07
- 52 Week High
- WFRD $135.00
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- WFRD 50.36
- BRKR 47.73
- Support Level
- WFRD $80.99
- BRKR $48.07
- Resistance Level
- WFRD $91.82
- BRKR $56.65
- Average True Range (ATR)
- WFRD 3.06
- BRKR 2.77
- MACD
- WFRD 0.23
- BRKR -0.16
- Stochastic Oscillator
- WFRD 52.06
- BRKR 55.07
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.